Fujisawa Pharmaceutical Co., Ltd.
Records under this name other than patents Fujisawa Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Fujisawa Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,129,232 | Cephem Compounds now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 8,470,783 | Medicinal Use of Histone Deacetylase Inhibitor and Method of Evaluating Antitumor Effect Thereof now held by Astellas Pharma Inc. Term ended Term ended Jul 8, 2025 · High confidence | Term ended | Term ended Jul 8, 2025 | High confidence |
| US 7,314,862 | Antitumor Agent now held by Astellas Pharma Inc. Term ended Term ended Sep 24, 2024 · High confidence | Term ended | Term ended Sep 24, 2024 | High confidence |
| US 8,673,888 | Depsipeptide for therapy of kidney cancer now held by Astellas Pharma Inc. Term ended Term ended Sep 24, 2024 · High confidence | Term ended | Term ended Sep 24, 2024 | High confidence |
| US 7,056,883 | Therapeutic Agent for Soft Tissue Sarcoma now held by Astellas Pharma Inc. Term ended Term ended Jun 25, 2024 · High confidence | Term ended | Term ended Jun 25, 2024 | High confidence |
| US 7,199,248 | New Process now held by Honeywell International, Inc. Term ended Term ended Jan 12, 2024 · High confidence | Term ended | Term ended Jan 12, 2024 | High confidence |
| US 7,402,435 | A Method of Transferring a Selected Molecule into a Cell now held by Y'S Corporation Term ended Term ended May 11, 2023 · High confidence | Term ended | Term ended May 11, 2023 | High confidence |
| US 7,919,653 | Method of Inhibiting Nonspecific Interaction Between Molecules on Solid Phase Support now held by Kobe Chemical Genetics, Co., Ltd. Lapsed on the fee record Ended Apr 5, 2023 · High confidence | Lapsed on the fee record | Ended Apr 5, 2023 | High confidence |
| US 7,202,211 | Methods of Preventing or Treating Brain Ischemia or Brain Injury now held by Quark Pharmacuticals, Inc. Term ended Term ended Feb 20, 2023 · High confidence | Term ended | Term ended Feb 20, 2023 | High confidence |
| US 6,927,230 | Triazole Derivatives now held by Astellas Pharma Inc. Term ended Term ended Oct 30, 2022 · High confidence | Term ended | Term ended Oct 30, 2022 | High confidence |